Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada
Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in CanadaView Video
Roundtable Discussion; The Future of Mineral Sands
Roundtable Discussion; The Future of Mineral SandsView Video

Latest Share Chat

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,728.50
Bid: 1,727.00
Ask: 1,728.00
Change: 23.50 (1.38%)
Spread: 1.00 (0.058%)
Open: 1,705.00
High: 1,729.50
Low: 1,695.50
Prev. Close: 1,705.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

US STOCKS-Wall St flat after retail sales, Nasdaq edges higher

Mon, 13th May 2013 16:41

* Core U.S. retail sales rise 0.5 percent in April

* Yum Brands falls as monthly Chinese sales drop

* Crude oil falls, pressuring energy companies

* Indexes: Dow down 0.2 pct, S&P up 0.1 pct, Nasdaq up 0.3pct

By Ryan Vlastelica

NEW YORK, May 13 (Reuters) - U.S. stocks were mostly flat onMonday as investors paused following a rally that took indexesto record highs, though a strong read on retail sales limiteddeclines and the Nasdaq ticked up on a rally in Netflix.

The S&P 500 has jumped more than 14 percent so far thisyear, a rally that has repeatedly taken it to record intradayand closing highs without sustained declines. While thelong-term trend is still viewed as positive, many analysts saidthe momentum could wane in the absence of positive catalysts.

Retail sales rose 0.1 percent in April, better than the 0.3percent drop that had been expected, and returning to growthfollowing a decline in March.

Excluding autos, gasoline and building materials, core salesrose 0.5 percent. Retail sales account for about 30 percent ofU.S. consumer spending.

"Recent data has been weak, so to see some sturdiness isimportant and needed in order for us to move materially higher,"said Mark Luschini, chief investment strategist at JanneyMontgomery Scott in Philadelphia. "But given the strength we'vehad over the past few weeks, it isn't surprising that trading isa bit indifferent today."

The S&P 500 managed its third straight weekly gainlast week, reaching a record high on Friday. The benchmark had a five-day streak of record closing highs before settling loweron Thursday.

The Dow Jones industrial average was down 24.04points, or 0.16 percent, at 15,094.45. The Standard & Poor's 500Index was up 1.41 points, or 0.09 percent, at 1,635.11.The Nasdaq Composite Index was up 8.40 points, or 0.24percent, at 3,444.99.

Netflix Inc jumped 4.2 percent to $226.81 as one ofthe biggest advancing stocks in the S&P 500, helping to keep theNasdaq in slightly positive territory.

Other data showed business inventories were unchanged inMarch for a second straight month versus expectations of 0.3percent rise, suggesting restocking could help second-quartereconomic growth.

Crude oil fell 0.7 percent to $95.39 per barrel,pressured by a drop to an eight-month low in demand in China.

Luschini, who helps oversee $58 billion in assets, said thedrop in oil and gasoline prices contributed to the strong readon retail sales, "so it is helpful to see those remain tame.

"However, if we dip below $90 a barrel, that will hurt theenergy sector and could be a signal of lower global growth."

Consol Energy fell 2 percent to $34.14 whileNational Oilwell Varco was off 1.4 percent at $67.27.

Yum Brands Inc fell 2.6 percent to $68.54. After themarket closed on Friday, the fast food chain operator posted asteep decline in Chinese April sales.

With 90 percent of the S&P 500 having reported, 67.2 percentof companies have topped earnings expectations, according toThomson Reuters data, an amount that is even with the averageover the past four quarters. Only 46.9 percent have beatenrevenue expectations, under the 52 percent average over the pastfour quarters.

Elan agreed to a $1 billion deal to buy 21percent of the royalties that U.S. company Theravance receives from GlaxoSmithKline for itsrespiratory drugs. Theravance shares jumped 15 percent to$40.33.

U.S.-listed shares of Perion Network surged 12percent to $14.10 after the Israeli consumer Internet companyposted first-quarter earnings.

SoftBank Corp has told banks that their financingof Dish Network Corp's $25.5 billion rival offer forSprint Nextel Corp could hurt their chances of landing arole in a highly anticipated public offering of Chinesee-commerce giant Alibaba Group Holding Ltd, two sources familiarwith the situation said.

Sprint shares dipped 1.6 percent to $7.24 while Dish lost1.7 percent to $38.51.

More News
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 17:10

Miners, personal goods stocks drag FTSE 100 to two-week low

Burberry slips on rating downgrade

*

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 12:10

LONDON MARKET MIDDAY: Stocks down before Fed minutes and US PMI data

(Alliance News) - Stock prices in London were down at midday on Wednesday, in cautious trade ahead of key US data and central bank minutes in the afternoon.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
29 Dec 2023 13:01

LONDON MARKET CLOSE: UK equities outclassed by other markets in 2023

(Alliance News) - Stock prices in London closed mixed on Friday, the final trading day of 2023, as the annual returns from UK equities were outshone by international markets.

Read more
20 Dec 2023 13:29

GSK buys rights to Hansoh Pharma antibody-drug conjugate

(Sharecast News) - GSK has agreed to buy the rights to an antibody-drug conjugate (ADC) - HS-20093 - from Chinese biopharmaceutical group Hansoh Pharma.

Read more
19 Dec 2023 15:36

German court quashes CureVac patent after challenge by BioNTech

CureVac shares drop 40%Dispute over intellectual property with BioNTech to continue

*

Read more
18 Dec 2023 17:21

Energy stocks lift UK's FTSE 100, Vodafone shines

Vodafone jumps as Iliad offers to merge Italian units

*

Read more
18 Dec 2023 10:07

GSK's dostarlimab trial in endometrial cancer meets primary endpoint

(Alliance News) - GSK PLC on Monday said a trial of dostarlimab in combination with niraparib for treating endometrial cancer has met its primary endpoint.

Read more
18 Dec 2023 07:55

LONDON BRIEFING: Games Workshop seals Amazon deal for Warhammer 40,000

(Alliance News) - Stocks in London were set to retreat slightly on Monday, in line with equity markets in Asia, at the start of the last week before the Christmas holidays.

Read more
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.